Morgan Stanley’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $440K | Sell |
|
|||||
|
2025
Q1 | $299K | Sell |
|
|||||
|
2024
Q4 | $374K | Buy |
|
|||||
|
2024
Q3 | $677K | Buy |
|
|||||
|
2024
Q2 | $514K | Buy |
|
|||||
|
2024
Q1 | $441K | Sell |
|
|||||
|
2023
Q4 | $615K | Buy |
|
|||||
|
2023
Q3 | $355K | Sell |
|
|||||
|
2023
Q2 | $267K | Sell |
|
|||||
|
2023
Q1 | $395K | Buy |
|
|||||
|
2022
Q4 | $43.8K | Buy |
|
|||||
|
2022
Q3 | $61K | Sell |
|
|||||
|
2022
Q2 | $77K | Sell |
|
|||||
|
2022
Q1 | $102K | Sell |
|
|||||
|
2021
Q4 | $194K | Buy |
|
|||||
|
2021
Q3 | $195K | Buy |
|
|||||
|
2021
Q2 | $131K | Buy |
|
|||||
|
2021
Q1 | $57K | Sell |
|
|||||
|
2020
Q4 | $121K | Buy |
|
|||||
|
2020
Q3 | $85K | Sell |
|
|||||
|
2020
Q2 | $199K | Buy |
|
|||||
|
2020
Q1 | $109K | Sell |
|
|||||
|
2019
Q4 | $468K | Buy |
|
|||||
|
2019
Q3 | $284K | Buy |
|
|||||
|
2019
Q2 | $222K | Sell |
|
|||||
|
2019
Q1 | $301K | Sell |
|
|||||
|
2018
Q4 | $213K | Buy |
|
|||||
|
2018
Q3 | $346K | Sell |
|
|||||
|
2018
Q2 | $391K | Buy |
|
|||||
|
2018
Q1 | $210K | Buy |
|
|||||
|
2017
Q4 | $54K | Sell |
|
|||||
|
2017
Q3 | $220K | Sell |
|
|||||
|
2017
Q2 | $267K | Buy |
|
|||||
|
2017
Q1 | $206K | Buy |
|
|||||
|
2016
Q4 | $7K | Sell |
|
|||||
|
2016
Q3 | $7K | Sell |
|
|||||
|
2016
Q2 | $12K | Buy |
|
|||||
|
2016
Q1 | $8K | Sell |
|
|||||
|
2015
Q4 | $17K | Sell |
|
|||||
|
2015
Q3 | $34K | Sell |
|
|||||
|
2015
Q2 | $74K | Buy |
|
|||||
|
2015
Q1 | $67K | Sell |
|
|||||
|
2014
Q4 | $347K | Buy |
|
|||||
|
2014
Q3 | $130K | Sell |
|
|||||
|
2014
Q2 | $1.17M | Sell |
|
|||||
|
2014
Q1 | $1.41M | Buy |
|
|||||
|
2013
Q4 | $143K | Buy |
|
|||||
|
2013
Q3 | $146K | Buy |
|